# Farmers & Merchants Bancorp: overview

FMCB · OTC · CIK 1085913 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fmcb.md) · [Financials](/companies/fmcb/financials.md) · [Filings](/companies/fmcb/filings.md) · [Insiders](/companies/fmcb/insiders.md)

Revenue is not reported in this company’s XBRL financial statements.

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | [29.96](/filings/0001140361-25-041120.md) | not reported | [32.86](/filings/0001140361-26-020057.md) | [32.94](/filings/0001140361-26-031718.md) | [33.92](/filings/0001140361-25-041120.md) | not reported | [35.34](/filings/0001140361-26-020057.md) | [36.39](/filings/0001140361-26-031718.md) |
| Free cash flow | $m | [34.9 d](/filings/0001140361-25-041120.md) | [12.2 d](/filings/0001140361-26-009383.md) | [38.9](/filings/0001140361-26-020057.md) | [18.9 d](/filings/0001140361-26-031718.md) | [27.4 d](/filings/0001140361-25-041120.md) | [11.5 d](/filings/0001140361-26-009383.md) | [31.2](/filings/0001140361-26-020057.md) | [29.5 d](/filings/0001140361-26-031718.md) |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | [84.01](/filings/0001140361-24-013280.md) | [96.55](/filings/0001140361-25-008871.md) | [116.61](/filings/0001140361-26-009383.md) | [121.02](/filings/0001140361-26-009383.md) | [133.96](/filings/0001140361-26-009383.md) |
| Free cash flow | $m | [57.9](/filings/0001140361-24-013280.md) | [97.6](/filings/0001140361-25-008871.md) | [88.4](/filings/0001140361-26-009383.md) | [101](/filings/0001140361-26-009383.md) | [96.6](/filings/0001140361-26-009383.md) |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/fmcb/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [Siena Capital Partners GP, LLC](/funds/1694886.md) | 2026-06-30 | $4.7m | 3,662 |  | Unchanged |
| [Ancora Advisors LLC](/funds/1446114.md) | 2026-06-30 | $14.1k | 11 |  | Unchanged |

## Recent filings

[All 940 filings](/companies/fmcb/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-21 | 16:17 ET | [8-K](/filings/0001085913-26-000004.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001085913-26-000004 |
| 2026-10-20 | 13:00 ET | [8-K](/filings/0001140361-26-040188.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-26-040188 |
| 2026-08-13 | 22:54 ET | [8-K](/filings/0001140361-26-032560.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-032560 |
| 2026-08-07 | 22:12 ET | [10-Q](/filings/0001140361-26-031718.md) | Quarterly report, period 2026-06-30 | 0001140361-26-031718 |
| 2026-07-23 | 18:45 ET | [8-K](/filings/0001140361-26-029401.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-029401 |
| 2026-07-20 | 20:30 ET | [8-K](/filings/0001140361-26-028971.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-26-028971 |
| 2026-06-11 | 20:49 ET | [8-K](/filings/0001140361-26-024952.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-26-024952 |
| 2026-05-13 | 23:29 ET | [8-K](/filings/0001140361-26-020886.md) | 5.07 Shareholder vote results | 0001140361-26-020886 |
| 2026-05-12 | 20:35 ET | [8-K](/filings/0001140361-26-020833.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-020833 |
| 2026-05-08 | 20:31 ET | [10-Q](/filings/0001140361-26-020057.md) | Quarterly report, period 2026-03-31 | 0001140361-26-020057 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001140361-26-009383.md), filed Mar 13, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1085913
- Tickers: FMCB
- Exchange: OTC
- SIC code: 6021 National Commercial Banks
- State of incorporation: DE
- Filer category: Accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:32 ET. No prices; not investment advice.